Clopidogrel ratiopharm Европейски съюз - английски - EMA (European Medicines Agency)

clopidogrel ratiopharm

archie samuel s.r.o. - clopidogrel - peripheral vascular diseases; stroke; myocardial infarction - antithrombotic agents - clopidogrel is indicated in adults for the prevention of atherothrombotic events in:patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. for further information please refer to section 5.1.